Abstract
The first clinical and biochemical description of two sisters affected with argininemia, last of the five primary disorders of the urea cycle, was published in 19691–3. A third sister homozygote was described shortly after birth five years later4. Five other families including eight cases have been reported in the literature5–10. The first clinical symptoms seen in patients with argininemia are irritability, coma and epilepsy. The children show also pyramidal spasticity and mental retardation. All the patients described are still alive. The patient’s biochemistry is characterized by an arginase deficiency in liver shown after biopsy as well as in erythrocytes and leucocytes. As a consequence to this arginase deficiency, the patients accumulate arginine in their cells and biological fluids. The arginine accumulation leads to an increase of its catabolites: the guanidino compounds. Already in 1972 it was reported that guanidinoacetic acid, N-α-acetylarginine, argininic acid, γ-guanidinobutyric acid, arginine and an unknown guanidino compound (later identified as being γ-keto-δ-guanidinovaleric acid11) were elevated in urine of these patients12. These determinations were done applying the colorimetric Sakaguchi detection method.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
H. G. Terheggen, A. Schwenk, A. Lowenthal, M. Van Sande and J. P. Colombo, Argininemia with arginase deficiency, Lancet, 2: 748–749 (1969).
H. G. Terheggen, A. Schwenk, A. Lowenthal, M. Van Sande and J. P. Colombo, Hyperargininämie mit Arginäsedefekt. Eine neue familiâre Stoffwechselstôrung, I. Klinische Befunde, Z. Kinderheilk., 107: 298–312 (1970).
H. G. Terheggen, A. Schwenk, A. Lowenthal, M. Van Sande and J. P. Colombo, Hyperargininäpiie mit Arginäsedefekt. Eine neue familiâre Stoffwechselstörung. II. Biochemische Untersuchungen, Z. Kinderheilk., 107: 313–323 (1970).
H. G. Terheggen, A. Lowenthal, F. Lavinha and J. P. Colombo, Familial hyperargininemia, Arch. Dis. Child., 50: 57–62 (1975).
S. D. Cederbaum, K. N. F. Shaw and M. Valente, Hyperargininemia, J. Pediatr., 90: 569–573 (1977).
V. V. Michels and A. L. Beaudet, Arginase deficiency in multiple tissues in argininemia, Clin. Genet., 13: 61–67 (1978).
S. E. Snyderman, C. Sansaricq, W. F. Chen, P. M. Norton and S. V. Phansalkar, Argininemia, J. Pediatr., 90: 563 (1977).
I. A. Qureshi, J. Letarte, R. Quellet, M. Leliévre and C. Laberge, Ammonia metabolism in a family affected by hyperargininemia, Diabète et Métabol., 7: 5 (1981).
I. A. Qureshi, J. Letarte, R. Quellet and J. Larochelle, A new French-Canadian family affected by hyperargininemia, Pediatr. Res., 16: 194A (1982).
M. Yoshino, K. Kubota, I. Yoshida, T. Murakami and F. Yamashita, Argininemia: report of a new case and mechanisms of orotic aciduria and hyperammonemia, in:“Urea Cycle Diseases,” A. Lowenthal, A. Mori and B. Marescau, eds., Advances in experimental medicine and biology, vol. 153, Plenum Press, New York, pp. 121–125 (1982).
B. Marescau, J. Pintens, A. Lowenthal, E. Esmans, Y. Luyten, G. Lemiere, R. Domisse, F. Alderweireldt and H. G. Terheggen, Isolation and identification of a-keto-S-guanidinovaleric acid in urine of patients with hyperargininemia by chromatography and gas chromatography-mass spectrometry, J. Clin. Chem. Biochem., 19: 61–65 (1981).
H. G. Terheggen, F. Lavinha, J. P. Colombo, M. Van Sande and A. Lowenthal, Familial hyperargininemia, J. Genet. Hum., 20: 69–84 (1972).
Y. Hiraga and T. Kinoshita, Post-colomn derivatization of guanidino compounds in high-performance liquid chromatography using ninhydrin, J. Chromat., 226: 43–51 (1981).
A. Mizuno, J. Mukawa, K. Kobayashi and A. Mori, Convulsive activity of taurocyamine in cats and rabbits, IRCS Med. Sci., 3: 385 (1975).
D. Junnai, A. Mori, J. Mukawa, H. Ohkusu, M. Hosotani, A. Mizuno and L.C. Tye, Biochemical and physiological studies on guanidino compounds induced convulsions, Jpn. J. Brain Physiol., 160: 3668–3673 (1969).
D. Jinnai, A. Sawai and A. Mori, y-Guanidinobutyric acid as a convulsive substance, Nature, 212: 617 (1966).
H. Ohkusu, Osaka-gakkai-Zashi, 21: 49–55 (1970).
A. Mori, Y. Watanabe, S. Shindo, M. Akagi and M. Hiramatsu, y-Guanidinoglutaric acid and epilepsy, in:“Urea Cycle diseases,” A. Lowenthal, A. Mori and B. Marescau, eds., Advances in experimental medicine and biology, vol. 153, Plenum Press, New York, pp. 419–426 (1982).
M. Matsumoto, K. Kobayashi, H. Kishikawa and A. Mori, Convulsive activity of methylguanidine in cats and rabbits, IRCS Med. Sci., 4: 65 (1976).
B. Marescau, M. Hiramatsu and A. Mori, a-keto-d-guanidinovaleric acid induced electroencephalographic, epileptiform discharges in rabbits, Neurochem. Pathol., in press.
A. Scott-Emuakpor, On the hydrolysis of homoarginine by arginase, J. West Afr. Sci. Ass., 17: 161–170 (1972).
G. Perez, A. Rey and E. Schiff, The biosynthesis of guanidinosuccinic acid by peffused rat liver, J. Clin. Invest., 57: 807–809 (1976).
S. Natelson and J. E. Sherwin, Proposed mechanism for urea nitrogen re-utilization. Relationship between urea and proposed guanidine cycles, Clin. Chem., 25: 1343–1344 (1979).
A. Lowenthal and B. Marescau, Urinary excretion fo monosubstituted guanidines in patients affected with urea cycle diseases, in:“6th International congress of neurogenetics and neuro-ophthalmology,” A. Huber and D. Klein, eds., Elsevier/North Holland Biomedical Press, Amsterdam, pp. 347–350 (1981).
N. V. Thoai and J. Roche, Biochemie du groupement guanidique, Exp. Ann. Biochim. Med., 18: 165–185 (1956).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Marescau, B., Qureshi, I.A., De Deyn, P., Letarte, J., Yoshino, M., Lowenthal, A. (1985). Determination of Guanidino Compounds in Plasma and Urine of Patients with Argininemia before and during Therapy. In: Mori, A., Cohen, B.D., Lowenthal, A. (eds) Guanidines. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0752-6_18
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0752-6_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0754-0
Online ISBN: 978-1-4757-0752-6
eBook Packages: Springer Book Archive